© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Sidharth Chhibbar to join in spring
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad

More articles/Ad

More articles

  • “Who remembers places?” ran a joke on social media as lockdowns swept the globe. The idea that something so fundamental could be forgotten so quickly applies to capital markets too. There, the joke might ask who remembers credit risk. But at a time when central banks seem keen to underwrite credit of almost every variety, maybe it doesn’t matter.
  • Paraguay continued the relative rush of Latin American issuance on Thursday with a heavily demanded $1bn 11 year bond becoming the second high yield sovereign from Latin America in two days to tap bond markets to fund Covid-19 mitigation.
  • Mexico proved its capital market prowess with a highly oversubscribed $6bn bond this week, despite facing a wave of downgrades, concerns about the contingent liability represented by Pemex, and investor fears that the government is reacting too slowly to the Covid-19 pandemic.
  • The coronavirus pandemic has made for a tumultuous time in corporate finance. Banks’ relationships with long-standing clients have come under strain, with lending conditions tightening just as some companies need a sudden injection of cash like never before. Bank of America’s dealings with FTSE 100 publishing and events company, Informa, provide one example of the difficult decisions facing lenders.
  • The CLO market is in the middle of the panic phase of the current crisis, and a new life cycle in the time of Covid-19 will run for two to three years before the sector normalizes, said speakers in a virtual panel held by IMN on Thursday.
  • After years of not only falling loan volumes but being trounced in their own back yard, Europe's banks finally seem to have an edge against their US counterparts. With loan pricing gapping out in response to the coronavirus pandemic, but companies desperate for cash, the continent's lenders are proving first port of call for local borrowers, leaving US and Asian banks less active. Silas Brown, Mariam Meskin and Mike Turner report.